Found: 62
Select item for more details and to access through your institution.
Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1459502
- By:
- Publication type:
- Article
The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
- Published in:
- Brain: A Journal of Neurology, 2015, v. 138, n. 4, p. 918, doi. 10.1093/brain/awv017
- By:
- Publication type:
- Article
Assessment of 2D conventional and synthetic MRI in multiple sclerosis.
- Published in:
- Neuroradiology, 2022, v. 64, n. 12, p. 2315, doi. 10.1007/s00234-022-02973-2
- By:
- Publication type:
- Article
Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score.
- Published in:
- Neuroradiology, 2021, v. 63, n. 7, p. 1031, doi. 10.1007/s00234-020-02604-8
- By:
- Publication type:
- Article
What is a clinically isolated syndrome in the 21st century?
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 4/5, p. 641, doi. 10.1177/13524585221149888
- By:
- Publication type:
- Article
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 169, doi. 10.1177/13524585221134213
- By:
- Publication type:
- Article
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 182, doi. 10.1177/13524585221134217
- By:
- Publication type:
- Article
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1138, doi. 10.1177/13524585221089540
- By:
- Publication type:
- Article
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 950, doi. 10.1177/13524585211053001
- By:
- Publication type:
- Article
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 6, p. 913, doi. 10.1177/1352458520988148
- By:
- Publication type:
- Article
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1658, doi. 10.1177/1352458519877810
- By:
- Publication type:
- Article
Multiple sclerosis management during the COVID-19 pandemic.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 10, p. 1163, doi. 10.1177/1352458520948231
- By:
- Publication type:
- Article
Aggressive multiple sclerosis (1): Towards a definition of the phenotype.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1031, doi. 10.1177/1352458520925369
- By:
- Publication type:
- Article
Aggressive multiple sclerosis (2): Treatment.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 9, p. 1045, doi. 10.1177/1352458520924595
- By:
- Publication type:
- Article
MOG-antibody-associated disease—getting the whole picture.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 1000, doi. 10.1177/1352458519882594
- By:
- Publication type:
- Article
Detection of central vein should be part of MS diagnostic criteria – No.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 4, p. 407, doi. 10.1177/1352458519895749
- By:
- Publication type:
- Article
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 14, p. 1845, doi. 10.1177/1352458519885110
- By:
- Publication type:
- Article
Oligoclonal bands do not represent dissemination in time in the 2017 revisions to the McDonald criteria.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 14, p. 1843, doi. 10.1177/1352458517735191
- By:
- Publication type:
- Article
Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 6, p. 721, doi. 10.1177/1352458517707070
- By:
- Publication type:
- Article
Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 322, doi. 10.1177/1352458517698052
- By:
- Publication type:
- Article
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 301, doi. 10.1177/1352458517697830
- By:
- Publication type:
- Article
Commentary on “Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis”.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
CSF examination still has value in the diagnosis of MS – Commentary.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1802, doi. 10.1177/1352458515575338
- By:
- Publication type:
- Article
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1240, doi. 10.1177/1352458515589774
- By:
- Publication type:
- Article
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 7, p. 866, doi. 10.1177/1352458514555785
- By:
- Publication type:
- Article
Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 13, p. 1721, doi. 10.1177/1352458514533397
- By:
- Publication type:
- Article
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing–remitting multiple sclerosis patients on high-dose interferon beta.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
NMO spectrum disorders: how wide is the spectrum?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082796
- By:
- Publication type:
- Article
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059953
- By:
- Publication type:
- Article
Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI.
- Published in:
- Journal of Magnetic Resonance Imaging, 2024, v. 60, n. 1, p. 258, doi. 10.1002/jmri.29046
- By:
- Publication type:
- Article
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2023, v. 80, n. 2, p. 151, doi. 10.1001/jamaneurol.2022.4655
- By:
- Publication type:
- Article
Associations of sNfL with clinico‐radiological measures in a large MS population.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 1, p. 84, doi. 10.1002/acn3.51704
- By:
- Publication type:
- Article
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 1, p. 30, doi. 10.1002/ana.25909
- By:
- Publication type:
- Article
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 4794, doi. 10.1007/s00415-024-12452-8
- By:
- Publication type:
- Article
Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 4, p. 1764, doi. 10.1007/s00415-021-10958-z
- By:
- Publication type:
- Article
Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 1, p. 452, doi. 10.1007/s00415-021-10823-z
- By:
- Publication type:
- Article
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 7, p. 1349, doi. 10.1007/s00415-016-8147-7
- By:
- Publication type:
- Article
What Fluid Biomarkers Tell Us at Different Stages of Multiple Sclerosis.
- Published in:
- touchREVIEWS in Neurology, 2024, v. 20, n. 1, p. 2, doi. 10.17925/usn.2024.20.1.1
- By:
- Publication type:
- Article
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e246345, doi. 10.1001/jamanetworkopen.2024.6345
- By:
- Publication type:
- Article
Non‐ADEM encephalitis in patients with myelin oligodendrocyte glycoprotein antibodies: a systematic review.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1515, doi. 10.1111/ene.15684
- By:
- Publication type:
- Article